Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · IEX Real-Time Price · USD
5.04
-0.06 (-1.18%)
At close: Apr 26, 2024, 4:00 PM
4.970
-0.070 (-1.39%)
After-hours: Apr 26, 2024, 5:30 PM EDT

Syros Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018201720162015
Market Capitalization
13516473202497293187256284-
Market Cap Growth
-126.02%-64.04%-59.37%69.48%56.45%-26.74%-10.00%--
Enterprise Value
5585-6913438622787184200-36
PE Ratio
-1.00-1.00-0.77-2.33-5.91-3.89-3.01-4.74-5.53-
PS Ratio
13.5616.524.888.6032.93147.9791.44232.39896.87-
PB Ratio
8.089.850.572.375.493.702.383.923.53-
P/FCF Ratio
-1.51-1.51-0.58-2.00-8.19-4.03-4.50-5.62-6.63-
P/OCF Ratio
-1.50-1.50-0.59-2.03-8.66-4.87-4.65-5.72-7.01-
EV/Sales Ratio
5.558.51-4.655.6925.59114.7742.52166.83632.34-113.73
EV/EBITDA Ratio
-0.54-0.540.79-1.68-4.88-3.13-1.44-3.50-4.311.23
EV/EBIT Ratio
-0.53-0.530.76-1.62-4.70-3.02-1.40-3.40-4.201.21
EV/FCF Ratio
-0.78-0.780.56-1.33-6.36-3.13-2.09-4.03-4.681.49
Debt / Equity Ratio
3.733.730.500.760.730.330.000.000.00-0.01
Debt / EBITDA Ratio
-0.40-0.40-0.73-0.82-0.84-0.360.000.000.00-0.01
Debt / FCF Ratio
-0.57-0.57-0.51-0.65-1.09-0.360.000.00-0.01-0.01
Quick Ratio
3.863.866.734.246.194.755.145.828.884.57
Current Ratio
3.953.956.874.346.244.875.215.898.944.58
Asset Turnover
0.060.060.070.110.090.020.020.010.000.01
Interest Coverage
-31.10-31.10-21.90-21.15-45.90-1046.75-62278.00---
Return on Equity (ROE)
-282.60%-282.60%-108.00%-73.50%-122.00%-86.30%-64.40%-70.80%-456.30%99.70%
Return on Assets (ROA)
-93.70%-93.70%-46.90%-39.10%-51.30%-56.50%-51.20%-62.80%-63.60%-66.10%
Return on Capital (ROIC)
-163.82%-163.82%-71.02%-66.10%-52.50%-73.97%-81.78%-83.65%-59.34%62.61%
Earnings Yield
-122.17%-100.28%-130.36%-42.86%-16.91%-25.72%-33.22%-21.11%-18.09%-
FCF Yield
-80.48%-66.06%-171.19%-49.91%-12.21%-24.82%-22.24%-17.80%-15.07%-
Buyback Yield / Dilution
-124.24%-124.24%-102.00%-35.79%-14.49%-23.17%-28.53%-100.11%-541.14%-29.85%
Total Shareholder Return
-124.24%-124.24%-102.00%-35.79%-14.49%-23.17%-28.53%-100.11%-541.14%-29.85%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).